P2.07C.01 LCMC3: Clinical Utility of Suvmax on Preoperative 18F-FDG PET-CT in Resectable NSCLC Treated with Neoadjuvant Atezolizumab.
| Autor: | Merritt, R., Patterson, G.A., Toloza, E.M., Lee, J.M., Raz, D.J., Baciewicz, F., Weyant, M., Molena, D., Isbell, J., Kim, J., Pass, H.I., Bunn, P.A., Johnson, B.E., Kris, M.G., Kwiatkowski, D.J., Wistuba, I.I., Bara, I., Gasior, G., Schulze, K., Brandão, E. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS240-S241, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|